[HTML][HTML] A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non–small-cell lung cancer of adenocarcinoma histology …
Y Shi, JSK Au, S Thongprasert, S Srinivasan… - Journal of thoracic …, 2014 - Elsevier
Introduction: PIONEER (NCT01185314) was a prospective, multinational, epidemiological
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
Y Shi, JSK Au, S Thongprasert, S Srinivasan, CM Tsai… - 2014 - cmuir.cmu.ac.th
INTRODUCTION:: PIONEER (NCT01185314) was a prospective, multinational,
epidemiological study of epidermal growth factor receptor (EGFR) mutations in patients from …
epidemiological study of epidermal growth factor receptor (EGFR) mutations in patients from …
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Y Shi, JS Au, S Thongprasert, S Srinivasan… - Journal of Thoracic …, 2014 - europepmc.org
Methods Eligible patients (aged≥ 20 years) had untreated stage IIIB/IV adenocarcinoma.
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
[PDF][PDF] A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology …
Y Shi, JSK Au, S Thongprasert… - Journal of Thoracic …, 2014 - researchgate.net
Methods: Eligible patients (aged≥ 20 years) had untreated stage IIIB/IV adenocarcinoma.
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
[PDF][PDF] A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology …
Y Shi, JSK Au, S Thongprasert, S Srinivasan… - Journal of Thoracic …, 2014 - academia.edu
Methods: Eligible patients (aged≥ 20 years) had untreated stage IIIB/IV adenocarcinoma.
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
[HTML][HTML] A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma …
Y Shi, JSK Au, S Thongprasert… - Journal of Thoracic …, 2014 - ncbi.nlm.nih.gov
Methods: Eligible patients (aged≥ 20 years) had untreated stage IIIB/IV adenocarcinoma.
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)
Y Shi, JSK Au, S Thongprasert… - Journal of thoracic …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction PIONEER (NCT01185314) was a prospective, multinational, epidemiological
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
[引用][C] A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology …
Y Shi, JSK Au, S Thongprasert, S Srinivasan… - Journal of Thoracic …, 2014 - cir.nii.ac.jp
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with
Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER) | CiNii …
Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER) | CiNii …
[HTML][HTML] A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma …
Y Shi, JSK Au, S Thongprasert, S Srinivasan… - Journal of Thoracic …, 2014 - jto.org
Introduction: PIONEER (NCT01185314) was a prospective, multinational, epidemiological
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
study of epidermal growth factor receptor (EGFR) mutations in patients from Asia with newly …
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Y Shi, JS Au, S Thongprasert, S Srinivasan… - Journal of Thoracic …, 2014 - europepmc.org
Methods Eligible patients (aged≥ 20 years) had untreated stage IIIB/IV adenocarcinoma.
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …
The EGFR mutation status (primary end point: positive, negative, or undetermined) of tumor …